跳至主要内容
临床试验/ISRCTN68905568
ISRCTN68905568已完成未知

Xpert MTB/RIF for diagnosis of tuberculosis: evaluating impact and cost-effectiveness in the routine roll-out in South Africa

Bill and Melinda Gates Foundation (USA)0 个研究点目标入组 4,400 人开始时间: 2011年11月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
4,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. The laboratories are placed in four Provinces geographically separate in serving a mix of clinics that have been allocated a GX16 Machine
  • 2. Tuberculosis (TB) suspected participants contribute towards samples evaluated in the laboratories
  • 3. Male and female participants
  • 4. Aged 18 and above

排除标准

  • 1. The laboratories part of other TB Xpert MTB/RIF evaluations
  • 2. Laboratories which already have an Xpert MTB/RIF instrument
  • 3. Laboratories which do not comply with standard of care TB diagnostics

研究者

发起方
Bill and Melinda Gates Foundation (USA)

相似试验